INCY logo

Incyte (INCY)

Profile

Full Name

Incyte Corporation

Ticker Symbol

INCY

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 4, 1993

Indexes

S&P 500

Website

http://www.incyte.com

Employees

2617

Key Details

Price

$68.17(-0.81%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$4.24B(+14.76% YoY)

Annual EPS

$0.15(-94.34% YoY)

PE ratio

213.03

Next earnings date

Jul 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $68.17
    INCY price is $68.17

    30-Day Relative Volume

    1.11
    INCY 30-day relative volume is 1.11

    Price Performance

    Price Today change

    -0.81%
    INCY price is down -0.81% today

    Price YTD change

    -1.3%
    INCY price is down -1.3% since January 1st

    Price 1-year change

    +15.5%
    INCY price is up +15.5% year-on-year

    Price 3-year change

    -12.23%
    INCY price is down -12.23% over the past 3 years

    Price Range

    Price All-time high

    $153.15
    INCY price is currently -55.49% below its historical high of $153.15

    Price 3-year low

    $50.27
    INCY price is currently +35.61% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $13.20B
    INCY market capitalization is $13.20 billion

    Market cap 3-year change

    -23.43%
    INCY market capitalization is down -23.43% over the past 3 years

    Market cap All-time high

    $31.12B
    INCY market capitalization is currently -57.59% below its historical high of $31.12 billion

    Market cap sector rank

    94.03%
    INCY market capitalization is higher than 94.03% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.04%
    INCY shares outstanding is up +1.04% year-on-year

    Shares Outstanding 3-Year Change

    -12.76%
    INCY shares outstanding is down -12.76% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.56
    INCY beta is 0.56

    200-day SMA

    $67.96
    INCY price is currently +0.31% above its 200-day simple moving average

    50-day SMA

    $64.80
    INCY price is currently +5.20% above its 50-day simple moving average

    RSI

    52.31
    INCY 14-day relative strength index is 52.31

    Volume

    1.11
    INCY 30-day relative volume is 1.11

    ATR

    $2.20
    INCY average true range is $2.20

    10-day Historical Volatility

    38.11%
    INCY 10-day historical volatility is 38.11%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $4.24B
    INCY annual revenue is $4.24 billion

    Revenue Analysts estimate

    $4.71B
    INCY annual revenue is currently -9.97% lower than the consensus analysts' forecast

    Revenue 1-year change

    +14.76%
    INCY annual revenue is up +14.76% year-on-year

    Revenue Sector rank

    91.07%
    INCY annual revenue is higher than 91.07% of companies in Healthcare sector

    EPS

    EPS

    $0.15
    INCY annual earnings per share is $0.15

    EPS Analysts estimate

    $5.82
    INCY annual earnings per share is currently -97.42% lower than the consensus analysts' forecast

    EPS 1-year change

    -94.34%
    INCY annual earnings per share is down -94.34% year-on-year

    EPS Sector rank

    84.27%
    INCY annual earnings per share is higher than 84.27% of companies in Healthcare sector

    Profit

    Gross profit

    $3.93B
    INCY annual gross profit is $3.93 billion

    Gross margin

    92.64%
    INCY annual gross profit margin is 92.64%

    Operating profit

    $101.29M
    INCY annual operating income is $101.29 million

    Operating margin

    2.39%
    INCY annual operating profit margin is 2.39%

    Net income

    $32.62M
    INCY annual net profit is $32.62 million

    Net margin

    0.77%
    INCY annual net profit margin is 0.77%

    Expenses

    Total expenses

    $4.14B
    INCY annual total expenses is $4.14 billion

    Operating expenses

    $3.83B
    INCY annual total operating expenses is $3.83 billion

    Cost of goods sold

    $312.10M
    INCY annual cost of goods sold is $312.10 million

    Selling, general & administrative expenses

    $1.22B
    INCY annual SGA is $1.22 billion

    Depreciation and amortization

    $89.25M
    INCY annual depreciation & amortization is $89.25 million

    Interest expense

    $2.28M
    INCY annual interest expense is $2.28 million

    Income tax

    $284.01M
    INCY annual income tax is $284.01 million

    EBIT & EBITDA

    EBIT

    $318.91M
    INCY annual earnings before interest & taxes is $318.91 million

    EBITDA

    $408.16M
    INCY annual EBITDA is $408.16 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $5.44B
    INCY annual total assets is $5.44 billion

    Non current assets

    $2.21B
    INCY annual long term assets is $2.21 billion

    Current assets

    $3.24B
    INCY annual total current assets is $3.24 billion

    Cash and cash equivalents

    $1.69B
    INCY annual cash & cash equivalents is $1.69 billion

    Accounts receivable

    $853.15M
    INCY annual accounts receivable is $853.15 million

    Inventory

    $58.87M
    INCY annual inventory is $58.87 million

    Liabilities

    Total liabilities

    $2.00B
    INCY annual total liabilities is $2.00 billion

    Long term liabilities

    $354.85M
    INCY annual total long term liabilities is $354.85 million

    Current liabilities

    $1.64B
    INCY annual total current liabilities is $1.64 billion

    Accounts payable

    $197.47M
    INCY annual accounts payable is $197.47 million

    Debt

    Total debt

    $43.54M
    INCY annual total debt is $43.54 million

    Total debt 1-year change

    +13.73%
    INCY annual total debt is up +13.73% year-on-year

    Long term debt

    $33.54M
    INCY annual long term debt is $33.54 million

    Short term debt

    $10.00M
    INCY annual short term debt is $10.00 million

    Equity & Capital

    Shareholders equity

    $3.45B
    INCY annual stockholders equity is $3.45 billion

    Book value

    $3.45B
    INCY annual book value is $3.45 billion

    Retained earnings

    -$1.07B
    INCY annual retained earnings is -$1.07 billion

    Working capital

    $1.60B
    INCY annual working capital is $1.60 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $335.34M
    INCY annual cash flow from operations is $335.34 million

    Cash from operations 1-year change

    -32.46%
    INCY annual cash flow from operations is down -32.46% year-on-year

    Cash from investing

    $157.52M
    INCY annual cash flow from investing activities is $157.52 million

    Cash from investing 1-year change

    +175.85%
    INCY annual cash flow from investing activities is up +175.85% year-on-year

    Cash from financing

    -$2.02B
    INCY annual cash flow from financing activities is -$2.02 billion

    Cash from financing 1-year change

    -9991.08%
    INCY annual cash flow from financing activities is down -9991.08% year-on-year

    CAPEX

    CAPEX

    $100.16M
    INCY annual capital expenditures is $100.16 million

    CAPEX 1-year change

    +110.93%
    INCY annual capital expenditures is up +110.93% year-on-year

    Free Cash Flow

    Free cash flow

    $235.17M
    INCY annual free cash flow is $235.17 million

    Free cash flow 1-year change

    -47.62%
    INCY annual free cash flow is down -47.62% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    92.64%
    INCY annual gross profit margin is 92.64%

    Operating margin

    2.39%
    INCY annual operating profit margin is 2.39%

    Net margin

    0.77%
    INCY annual net profit margin is 0.77%

    ROA & ROE

    ROA

    0.53%
    INCY annual return on assets is 0.53%

    ROE

    0.76%
    INCY annual return on equity is 0.76%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    213.03
    INCY price to earnings ratio is 213.03

    PE ratio Sector rank

    96.73%
    INCY price to earnings ratio is higher than 96.73% of companies in Healthcare sector

    PB Ratio

    PB ratio

    3.60
    INCY price to book ratio is 3.60

    PB ratio Sector rank

    72.81%
    INCY price to book ratio is higher than 72.81% of companies in Healthcare sector

    PS Ratio

    PS ratio

    2.99
    INCY price to sales ratio is 2.99

    PS ratio Sector rank

    50.99%
    INCY price to sales ratio is higher than 50.99% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $11.30B
    INCY enterprise value is $11.30 billion

    Enterprise value Sector rank

    92.41%
    INCY enterprise value is higher than 92.41% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    27.77
    INCY EV/EBITDA is 27.77

    EV/EBITDA Sector rank

    93.9%
    INCY EV/EBITDA is higher than 93.9% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.97
    INCY annual current ratio is 1.97

    Quick ratio

    1.94
    INCY annual quick ratio is 1.94

    Leverage

    Debt to equity

    0.00
    INCY annual debt to equity ratio is 0.00

    Interest coverage ratio

    139.87
    INCY annual interest coverage ratio is 139.87

    Risk & Stability

    Piotroski F-Score

    6
    INCY piotroski f-score is 6

    Altman Z-Score

    5.01
    INCY altman z-score is 5.01

    Analyst ratings

    Recent major analysts updates

    Jun 16, 25 Stifel
    Buy
    Jun 3, 25 UBS
    Neutral
    May 27, 25 Truist Securities
    Hold
    Apr 30, 25 Wells Fargo
    Equal-Weight
    Apr 30, 25 RBC Capital
    Sector Perform
    Apr 21, 25 JP Morgan
    Neutral
    Mar 24, 25 Morgan Stanley
    Equal-Weight
    Mar 18, 25 William Blair
    Market Perform
    Mar 18, 25 Truist Securities
    Hold
    Mar 18, 25 Guggenheim
    Neutral

    Institutional Ownership

    Screeners with INCY included

    Growing Shares Outstanding
    US stocks
    High Piotroski score stocks
    S&P 500 companies earnings calendar
    Most recommended stocks
    NASDAQ Dividend Calendar
    S&P 500 companies
    Stocks below analysts price target
    S&P 500 companies dividend calendar
    Healthcare sector
    • What is the ticker symbol for Incyte?
    • Does Incyte pay dividends?
    • What sector is Incyte in?
    • What industry is Incyte in?
    • What country is Incyte based in?
    • When did Incyte go public?
    • Is Incyte in the S&P 500?
    • Is Incyte in the NASDAQ 100?
    • Is Incyte in the Dow Jones?
    • When was Incyte's last earnings report?
    • When does Incyte report earnings?
    • Should I buy Incyte stock now?

    What is the ticker symbol for Incyte?

    The ticker symbol for Incyte is NASDAQ:INCY

    Does Incyte pay dividends?

    No, Incyte does not pay dividends

    What sector is Incyte in?

    Incyte is in the Healthcare sector

    What industry is Incyte in?

    Incyte is in the Biotechnology industry

    What country is Incyte based in?

    Incyte is headquartered in United States

    When did Incyte go public?

    Incyte's initial public offering (IPO) was on November 4, 1993

    Is Incyte in the S&P 500?

    Yes, Incyte is included in the S&P 500 index

    Is Incyte in the NASDAQ 100?

    No, Incyte is not included in the NASDAQ 100 index

    Is Incyte in the Dow Jones?

    No, Incyte is not included in the Dow Jones index

    When was Incyte's last earnings report?

    Incyte's most recent earnings report was on Apr 29, 2025

    When does Incyte report earnings?

    The next expected earnings date for Incyte is Jul 30, 2025

    Should I buy Incyte stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page